Letrozole Archives - Medical Conferences

Shaky OS results of palbociclib in ER-positive/HER2-negative breast cancer

Presented By

Prof. Richard Finn, David Geffen School of Medicine at UCLA, CA, USA

Trial

Phase 3, PALOMA-2

Conference

ASCO 2022

Type

Peer-reviewed article

5 August 2022 12:09

ctDNA is prognostic and predictive for response to ribociclib plus letrozole

Presented By

Dr Giampaolo Bianchini, San Raffaele Scientific Institute, Italy

Trial

Phase 3, BioItaLEE

Conference

SABCS 2021

Type

Peer-reviewed article

31 January 2022 17:13

Longest survival benefit from first-line CDK4/6 inhibitor

Presented By

Prof. Gabriel Hortobagyi, University of Texas MD Anderson Cancer Center, USA

Trial

Phase 3, MONALEESA-2

Conference

ESMO 2021

Type

Peer-reviewed article

19 November 2021 09:50

Postmenopausal breast cancer: extended letrozole reduces recurrence

Presented By

Prof. Lucia Del Mastro, University of Genoa, Italy

Trial

Phase 3

Conference

ESMO 2021

Type

Peer-reviewed article

19 November 2021 09:47

Asian women also benefit from palbociclib plus letrozole

Presented By

Prof. Binghe Xu, Peking Union Medical College, Beijing, China

Trial

Phase 3, PALOMA-4

Conference

ESMO 2021

Type

Peer-reviewed article

19 November 2021 09:47

Palbociclib effective in ER-positive endometrial cancer

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:23

High rates of ROR-low disease with chemotherapy-free regimen in HR+/HER2- patients

Trial

Phase 2, CORALLEEN

Conference

SABCS 2019

Type

Peer-reviewed article

13 February 2020 23:05